Regulatory Processes Governing the Cell Surface Expression of LH and FSH Receptors - GPCR Signalling Complexes: Synthesis, Assembly, Trafficking and Specificity - page 123

Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, Bouvier M (2004) Homodimerization
of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem
279(32):33390-33397
Segaloff DL (2009) Diseases associated with mutations of the human lutropin receptor. Prog Mol
Biol Transl Sci 89C:97-114. doi: 10.1016/S1877-1173(09)89004-2 , pii:S1877-1173(09)89004-2
Segaloff DL, Ascoli M (1993) The lutropin/choriogonadotropin (LH/CG) receptor-4 years later.
Endocr Rev 14:324-347
Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry,
molecular biology, physiology, and pathophysiology. Endocr Rev 18:739-773
Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S (2003) Ovarian hyper-
stimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J
Med 349(8):760-766
Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH (1990) The testicular receptor for
follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol
Endocrinol 4:525-530
Srisuparp S, Strakova Z, Brudney A, Mukherjee S, Reierstad S, Hunzicker-Dunn M, Fazleabas
AT (2003) Signal transduction pathways activated by chorionic gonadotropin in the primate
endometrial epithelial cells. Biol Reprod 68(2):457-464
Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB,
Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB,
Moonga BS, Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125(2):247-260.
doi: 10.1016/j.cell.2006.01.051

Tao YX (2006) Inactivating mutations of G protein-coupled receptors and diseases: structure-
function insights and therapeutic implications. Pharmacol Ther 111(3):949-973. doi: 10.1016/j.
pharmthera.2006.02.008 , pii:S0163-7258(06)00028-3
Tao YX, Johnson NB, Segaloff DL (2004) Constitutive and agonist-dependent self-association of
the cell surface human lutropin receptor. J Biol Chem 279(7):5904-5914
Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, Bouvier
M (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodi-
mers during biosynthesis. Mol Endocrinol 17(4):677-691
Thomas D, Rozell TG, Liu X, Segaloff DL (1996) Mutational analyses of the extracellular domain
of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repaets 1-6 are
involved in hormone binding. Mol Endocrinol 10:760-768
Thomas RM, Nechamen CA, Mazurkiewicz JE, Muda M, Palmer S, Dias JA (2007) Follice-stimulating
hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic process-
ing. Endocrinology 148(5):1987-1995. doi: 10.1210/en.2006-1672 , pii:en.2006-1672
Trombetta ES, Helenius A (1998) Lectins as chaperones in glycoprotein folding. Curr Opin Struct
Biol 8(5):587-592
Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G,
Costagliola S (2005) Glycoprotein hormone receptors: link between receptor homodimeriza-
tion and negative cooperativity. EMBO J 24(11):1954-1964
Vasseur C, Rodien P, Beau I, Desroches A, Gerard C, de Poncheville L, Chaplot S, Savagner F, Croue
A, Mathieu E, Lahlou N, Descamps P, Misrahi M (2003) A chorionic gonadotropin-sensitive
mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous
ovarian hyperstimulation syndrome. N Engl J Med 349(8):753-759
Vassilakos A, Michalak M, Lehrman MA, Williams DB (1998) Oligosaccharide binding character-
istics of the molecular chaperones calnexin and calreticulin. Biochemistry 37(10):3480-3490
Xie YB, Wang H, Segaloff DL (1990) Extracellular domain of lutropin/choriogonadotropin recep-
tor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem
265:21411-21414
Zhang M, Mizrachi D, Fanelli F, Segaloff DL (2005) The formation of a salt bridge between
helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness
of the naturally occurring L457R mutation of the human lutropin receptor. J Biol Chem
280(28):26169-26176